PharmaBlock Sciences (Nanjing), Inc. (300725.SZ)
CNY 35.85
(0.25%)
CNY 35.85
(0.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 274.7 Million | 246.6 Million | 238.02 Million | 271.5 Million | 127.04 Million | 160.16 Million |
| Net Income | 197.36 Million | 325.89 Million | 503.76 Million | 184.2 Million | 152.07 Million | 134.49 Million |
| Depreciation & Amortization | 121.58 Million | 88.03 Million | 54.99 Million | 24.47 Million | 21.11 Million | 16.9 Million |
| Deferred income taxes | 1.34 Million | -13.13 Million | -11.38 Million | -7.43 Million | -43.04 Thousand | -1.45 Million |
| Stock-based compensation | 15.41 Million | 24.94 Million | 32.23 Million | 48.58 Million | 11.12 Million | - |
| Change in working capital | -215.14 Million | -216.02 Million | -155.12 Million | -16.44 Million | -63.95 Million | 6.12 Million |
| Other non-cash items | 627.86 Million | 36.89 Million | -186.45 Million | 38.12 Million | 6.72 Million | 2.63 Million |
| Investing Cash Flow | -971.64 Million | -593.63 Million | -914.34 Million | -144.58 Million | -300.66 Million | -39.09 Million |
| Investments in PPE | -315.77 Million | -557.9 Million | -505.75 Million | -75.17 Million | -173.52 Million | -48.43 Million |
| Acquisitions | -29.37 Million | -460.4 Million | -152.58 Million | 75.19 Million | -10.36 Million | -988.03 Thousand |
| Investment purchases | -3.86 Billion | -4.45 Billion | -2.54 Billion | -662.22 Million | -1.09 Billion | -741.08 Million |
| Sales/Maturities of investments | 3.23 Billion | 4.41 Billion | 2.28 Billion | 592.8 Million | 972.98 Million | 751.4 Million |
| Other Investing Activities | -31.47 Million | 460.68 Million | 203.28 Thousand | -75.17 Million | 251.18 Thousand | 0.74 |
| Financing Cash Flow | 65.37 Million | 760.36 Million | 145.22 Million | 992.66 Million | 51.09 Million | -19.44 Million |
| Debt repayment | -128.91 Million | -706.76 Million | -121.14 Million | -90.86 Million | -33.22 Million | -4.6 Million |
| Dividends payments | -19.96 Million | -19.96 Million | -15.36 Million | -21.71 Million | -22 Million | -15.66 Million |
| Common Stock Repurchased | -20.03 Million | -1.01 Million | - | -955.62 Million | -54.22 Million | - |
| Common Stock Issuance | - | 1.01 Million | - | 955.62 Million | 54.22 Million | - |
| Other Financing Activities | -21.72 Million | 1.5 Billion | 288.75 Million | 1.1 Billion | 109.58 Million | 824.45 Thousand |
| Accounts receivables | 37.37 Million | -31.42 Million | -133.74 Million | -100.89 Million | -68.58 Million | -7.65 Million |
| Accounts payables | -177.78 Million | 66.18 Million | 41.78 Million | 199.71 Million | 69.54 Million | 45.11 Million |
| Inventory | -74.73 Million | -237.66 Million | -51.77 Million | -107.81 Million | -64.87 Million | -29.88 Million |
| Other working capital | 15.41 Million | -13.13 Million | -11.38 Million | -7.43 Million | -43.04 Thousand | 36 Million |
| Cash at beginning of period | 1.15 Billion | 692.62 Million | 1.24 Billion | 144.57 Million | 264.46 Million | 157.56 Million |
| Cash at end of period | 511.18 Million | 1.13 Billion | 692.62 Million | 1.24 Billion | 144.57 Million | 264.46 Million |
| Capital Expenditure | -315.77 Million | -557.9 Million | -505.75 Million | -75.17 Million | -173.52 Million | -48.43 Million |
| Effect of forex changes on cash | 1.89 Million | 31.99 Million | -16.99 Million | -23.44 Million | 2.63 Million | 5.28 Million |
| Net cash flow / Change in cash | -639.08 Million | 445.32 Million | -548.09 Million | 1.09 Billion | -119.88 Million | 106.9 Million |
| Free Cash Flow | -41.06 Million | -311.29 Million | -267.72 Million | 196.32 Million | -46.47 Million | 111.72 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 33.09 Million | 49.2 Million | 49.48 Million | 197.36 Million | 43.31 Million | 40.15 Million |
| Depreciation & Amortization | - | 34.64 Million | 34.64 Million | 121.58 Million | 31.57 Million | -54.98 Million |
| Deferred income taxes | - | - | - | 1.34 Million | - | -72.65 Million |
| Stock-based compensation | - | 6.04 Million | - | 15.41 Million | 15.41 Million | -11.08 Million |
| Change in working capital | - | -70.86 Million | - | -215.14 Million | -21.94 Million | 135.87 Million |
| Other non-cash items | 33.97 Million | 78.37 Million | 11.4 Million | 627.86 Million | 93.48 Million | -2.37 Million |
| Investing Cash Flow | -115.04 Million | 13.67 Million | 63.37 Million | -971.64 Million | -497.65 Million | -158.25 Million |
| Investments in PPE | -14.09 Million | -40.99 Million | -18.73 Million | -315.77 Million | -20.97 Million | -85.13 Million |
| Acquisitions | 48.73 Thousand | 253.54 Thousand | - | -29.37 Million | -30.14 Million | 530.53 Thousand |
| Investment purchases | -1.25 Billion | -1.05 Billion | -380 Million | -3.86 Billion | -2.15 Billion | -1.03 Billion |
| Sales/Maturities of investments | 1.15 Billion | 1.1 Billion | 473.1 Million | 3.23 Billion | 1.71 Billion | 957.84 Million |
| Other Investing Activities | - | 253.54 Thousand | -10.99 Million | -31.47 Million | -469.71 Million | 1.22 |
| Financing Cash Flow | 92.04 Million | -273.02 Million | -196.09 Million | 65.37 Million | -140.96 Million | 27.56 Million |
| Debt repayment | -96.89 Million | -203.26 Million | -182.39 Million | -128.91 Million | -116.5 Million | -96.17 Million |
| Dividends payments | - | -61.57 Million | -3.69 Million | -19.96 Million | -19.96 Million | -19.96 Million |
| Common Stock Repurchased | 10 Million | -10 Million | - | -20.03 Million | -20.03 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -14.86 Million | 1.81 Million | -13.7 Million | -21.72 Million | 17.35 Million | 128.7 Million |
| Accounts receivables | - | 46.69 Million | - | 37.37 Million | 37.37 Million | 54.5 Million |
| Accounts payables | - | - | - | -177.78 Million | - | 12.28 Million |
| Inventory | - | -124.02 Million | - | -74.73 Million | -74.73 Million | 81.36 Million |
| Other working capital | - | 6.46 Million | - | 15.41 Million | 15.41 Million | -12.28 Million |
| Cash at beginning of period | 283.26 Million | 440.09 Million | 511.18 Million | 1.15 Billion | 1.05 Billion | 1.16 Billion |
| Cash at end of period | 312.25 Million | 283.26 Million | 440.09 Million | 511.18 Million | 511.18 Million | 1.05 Billion |
| Capital Expenditure | -14.09 Million | -40.99 Million | -18.73 Million | -315.77 Million | -20.97 Million | -85.13 Million |
| Effect of forex changes on cash | - | 9.58 Million | 3.66 Million | 1.89 Million | -12.29 Million | -11.94 Million |
| Net cash flow / Change in cash | 28.99 Million | -156.83 Million | -71.08 Million | -639.08 Million | -547.26 Million | -107.7 Million |
| Free Cash Flow | 52.97 Million | 51.93 Million | 42.14 Million | -41.06 Million | 84.24 Million | -50.19 Million |
NCRBF
4166
NATR
1766
6347
HMU